Advanced search
Publication Cover
Clinical and Experimental Hypertension. Part A: Theory and Practice Volume 10, 1988 - Issue 5
Journal homepage
3
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Enalapril & Nifedipine in Essential Hypertension: Synergism of the Hypotensive Effects in Combination

Trefor MorganDepartment of Physiology, University of Melbourne, Parkville, Australia;Hypertension Clinic, Repatriation Hospital, Heidelberg, Australia;Faculty of Medicine, Epidemiology Unit, University of Melbourne, Parkville, Australia
,
Adrianne AndersonDepartment of Physiology, University of Melbourne, Parkville, Australia;Hypertension Clinic, Repatriation Hospital, Heidelberg, Australia;Faculty of Medicine, Epidemiology Unit, University of Melbourne, Parkville, Australia
&
John HopperDepartment of Physiology, University of Melbourne, Parkville, Australia;Hypertension Clinic, Repatriation Hospital, Heidelberg, Australia;Faculty of Medicine, Epidemiology Unit, University of Melbourne, Parkville, Australia
Pages 779-789 | Published online: 23 May 2017

  • Buhler FR, Hulthen UL, Kiowski W, Muller FB, Bolli P. The place of the calcium antagonist verapamil in antihypertensive therapy. J Cardiovascular Pharmacol 1984; 4 (suppl 2): S350–S357.
  • Petrie JC, Jeffers TA, Scott AK, Webster J. Dose and duration of response to beta-blockers in the treatment of hypertension. Drugs 1983; 25 (suppl 2): 26–29.
  • Cashman PW, Cheung HS, Sabo EF, Ondetti MA. Design of potent competitive inhibitor of angiotensin converting enzyme. Carboxyalkaroyl and mercaptoalkanoyl amino acids. Biochemistry 1977; 16: 5484–5491.
  • Lessem JN, Rucinska E, Bickers FF et al. Long term enalapril. A new converting enzyme inhibitor in the treatment of mild to moderate hypertension. Results on a world wide multiclinic study. Clin Exp Hypertension 1985; 7: 1515–1539.
  • Vidt DG. A controlled multiclinic study to compare the antihypertensive effects of MK421, hydrochlorothiazide and MK421 combined with hydrochlorothiazide in patients with mild to moderate essential hypertension. J Hypertension 1984; 2 (suppl 2): 81–88.
  • Helgeland A, Strommen R, Hagelund CH, Tretli S. Enalapril, atenolol and hydrochlorothiazide in mild to moderate hypertension. A comparative multicentre study in general practice in Norway. Lancet 1986; 1: 872–875.
  • Andren L, Karlberg B, Ohman P, Svensson A, Asplund J, Hansson L. Captopril and atenolol combined with hydrochlorothiazide in essential hypertension. Br J Clin Pharmacol 1982; 14: 107S–111S.
  • MacGregor GA, Markandu ND, Smith SJ, Sagnella GA. Captopril: contrasting effects of adding hydrochlorothiazide, propranolol or nifedipine. J Cardiovasc Pharmacol 1985; 7: S82–S87.
  • Chalmers JP, Wing LMH, West MJ, Bune AJC, Elliott JM, Morris MJ, Cain MD, Graham JR and Southgate DO. Effects of enalapril and hydrochlorothiazide on blood pressure, renin-angiotensin system and atrial natriuretic factor in essential hypertension: a double- blind factorial cross-over study. Aust NZ J Med 1986; 16: 475–480.
  • Snedecor GW, Cochran WG. Statistical methods. 7th ed. Ames: Iowa University Press, 1980.
  • Baker RJ, Nelder JA. GLIM Manual (release 3). Oxford: Numerical Algorithms Group, 1978.
  • Morgan T, Anderson A. Interaction in hypertensive man between sodium intake, converting enzyme inhibitor (enalapril), plasma renin and blood pressure control. Journal of Human Hypertension (In press).
  • Wing LMH, Chalmers JP, West MJ, Bune AJC, Russell AE, Elliott JM. Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol. Contrasts in hypotensive interactions. Third European Meeting in Hypertension (Abstracts), 1987; 617.
  • Morgan T, Anderson A, Wilson D, Myers J, Murphy J, Nowson C. Paradoxical effect of sodium restriction on blood pressure in people on slow channel calcium blocking drugs. Lancet 1986; 1: 793.
  • Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 2: 347–504.
  • Morgan T, Davis JM. Renin secretion at the individual nephron level. Pflugers Arch 1975; 359: 23–31.
  • Hostetter TH, Troy JL and Brenner BM. Glomerular haemodynamics in experimental diabetes mellitus. Kidney International 1982; 21: 683–688.
  • Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG and Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925–1930.
  • Hommel E, Parving HH, Mathiesen E, Edsberg B, Nielson MD and Giese J. Effect of Captopril on kidney function in insulin dependent diabetic patients with nephropathy. Brit Med J 1986; 293: 467–471.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.